Survival benefit from immunocheckpoint inhibitors in stage IV non‐small cell lung cancer patients with brain metastases: A National Cancer Database propensity‐matched analysis

by Shinkichi Takamori, Takefumi Komiya, Emily Powell
Published 2021-02-01

Prognostic Impact of Single and Multiple Descriptors in Pathologically Staged T3N0M0 NSCLC

by Takefumi Komiya, MD, PhD, Emily Powell, PhD, Shinkichi Takamori, MD, PhD
Published 2021-03-01

Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation

by Shinkichi Takamori, Taichi Matsubara, Takatoshi Fujishita, Kensaku Ito, Ryo Toyozawa, Takashi Seto, Masafumi Yamaguchi, Tatsuro Okamoto
Published 2021-03-01

Brain cavernous hemangioma mimicking radiation‐induced necrosis in a patient with non‐small cell lung cancer

by Shinkichi Takamori, Takashi Seto, Mikako Jinnouchi, Taichi Matsubara, Naoki Haratake, Naoko Miura, Ryo Toyozawa, Masafumi Yamaguchi, Mitsuhiro Takenoyama
Published 2020-07-01

Targeted Therapy for RET Fusion Lung Cancer: Breakthrough and Unresolved Issue

by Shinkichi Takamori, Taichi Matsubara, Naoki Haratake, Gouji Toyokawa, Takatoshi Fujishita, Ryo Toyozawa, Kensaku Ito, Masafumi Yamaguchi, Kenichi Taguchi, Tatsuro Okamoto, Takashi Seto
Published 2021-08-01

Sarcoid‐like reaction of the extrathoracic lymph node in a patient with lung adenocarcinoma treated with pembrolizumab

by Shinkichi Takamori, Nobuki Furubayashi, Kenichi Taguchi, Taichi Matsubara, Takatoshi Fujishita, Kensaku Ito, Masafumi Yamaguchi, Ryo Toyozawa, Takashi Seto, Takahito Negishi, Motonobu Nakamura, Tatsuro Okamoto
Published 2021-07-01

Short progression‐free survival of ALK inhibitors sensitive to secondary mutations in ALK‐positive NSCLC patients

by Naoki Haratake, Takashi Seto, Shinkichi Takamori, Ryo Toyozawa, Kaname Nosaki, Naoko Miura, Taro Ohba, Gouji Toyokawa, Kenichi Taguchi, Masafumi Yamaguchi, Mototsugu Shimokawa, Mitsuhiro Takenoyama
Published 2019-09-01

Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression.

by Kazuki Takada, Tatsuro Okamoto, Masaki Tominaga, Koji Teraishi, Takaki Akamine, Shinkichi Takamori, Masakazu Katsura, Gouji Toyokawa, Fumihiro Shoji, Masaki Okamoto, Yoshinao Oda, Tomoaki Hoshino, Yoshihiko Maehara
Published 2017-01-01

Clinical significance of preoperative inflammatory markers in non-small cell lung cancer patients: A multicenter retrospective study.

by Kazuki Takada, Shinkichi Takamori, Taichi Matsubara, Naoki Haratake, Takaki Akamine, Fumihiko Kinoshita, Yuki Ono, Sho Wakasu, Kensuke Tanaka, Yuka Oku, Taro Oba, Atsushi Osoegawa, Tetsuzo Tagawa, Mitsuhiro Takenoyama, Mototsugu Shimokawa, Yoshinao Oda, Masaki Mori
Published 2020-01-01

The significant influence of having children on the postoperative prognosis of patients with nonsmall cell lung cancer: A propensity score‐matched analysis

by Shinkichi Takamori, Tetsuzo Tagawa, Gouji Toyokawa, Hiroki Ueo, Mototsugu Shimokawa, Fumihiko Kinoshita, Taichi Matsubara, Yuka Kozuma, Naoki Haratake, Takaki Akamine, Masakazu Katsura, Kazuki Takada, Fumihiko Hirai, Fumihiro Shoji, Tatsuro Okamoto, Yoshinao Oda, Yoshihiko Maehara
Published 2018-07-01

Lorlatinib-Induced Pulmonary Embolism in a Patient With an ALK-Positive NSCLC

by Ryo Toyozawa, MD, Naoki Haratake, MD, PhD, Gouji Toyokawa, MD, PhD, Taichi Matsubara, MD, PhD, Shinkichi Takamori, MD, PhD, Naoko Miura, MD, Masafumi Yamaguchi, MD, PhD, Mitsuhiro Takenoyama, MD, PhD, Takashi Seto, MD, PhD
Published 2020-06-01

Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC

by Ryo Toyozawa, MD, Naoki Haratake, MD, PhD, Gouji Toyokawa, MD, PhD, Taichi Matsubara, MD, PhD, Shinkichi Takamori, MD, PhD, Naoko Miura, MD, PhD, Masafumi Yamaguchi, MD, PhD, Mitsuhiro Takenoyama, MD, PhD, Takashi Seto, MD, PhD
Published 2020-03-01